News

Sanofi is paying $129 per share in cash for Blueprint, amounting to a $9.1 billion equity value and a 27% premium on the biotech’s closing price on Friday.
On the diesel front, the 300 SD straight-six lump with 148 horsepower and 229 pound-feet (310 Nm) of torque had to suffice. As for the gasoline-loving customers, they were offered a sixer in the ...
Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other ...
The heftiest member of the W140 S-class line — the S600 SEL — featured a fearsome 5,987cc V12 engine with an output of 408 horsepower. Open it up on the highway, and you're looking at top ...
The two companies said on Monday that Sanofi would initially pay $129.00 per share in cash, or around $9.1 billion. Blueprint shares jumped 27% to $128.74 in premarket trade.
PARIS (Reuters) -France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in rare immunology diseases, in the biggest deal struck ...
Sacco has always been a household name at the Three-Point Star and is credited as being the father of the W126, W140, and W220 generations of S-Class, to the R129 SL Roadster, the W202 and W203 C ...
Blueprint was prepared to spend $5,537,927 on the redesign. It is unclear where these funds will be shifted to now. The agency is still eager to work something out with FDOT if possible, but the ...
The virtual artist, better known as vladimirloktionov on social media, has presented a W140 third-generation Mercedes-Benz S-Class as his latest unofficial, hypothetical, and independent design ...
He believes the Blueprint will be further adjusted during next year’s legislative session in 2026. But only slightly. He says the big changes will come in 2027 after next year’s mid-term ...
It's funny how perception works. Most people consider the W140-codenamed Mercedes-Benz S-Class from the 1990s as the behemoth of the series, but did you ...